Wen Zhang

11PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 29, 2026
PD-L1 expression on circulating tumor cells for predicting clinical outcomes in patients with hepatocellular carcinoma receiving PD-(L)1 blockade and targeted therapy.

Caifeng Gong, Shuhui You, Qi Zhang

|Dec 19, 2025
Peripheral TERT- positive leukocytes as a biomarker of the local and systemic immune failure in early-stage lung adenocarcinoma progression.

Qi Zhang, Xiaoli Zhang, Guoliang Li

|Oct 30, 2025
Diagnostic and Predictive Value of CD133-Positive Circulating Tumor Cells as an Indicator of Pathological High-Risk Factors for Stage I Non-Small Cell Lung Cancer.

Huandong Huo, Xiaoli Zhang, Qi Zhang

|Nov 14, 2024
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.

Bingqing Shang, Zhilong Hu, Ruiyang Xie

|Jul 01, 2024
Organoid co-culture models of the tumor microenvironment promote precision medicine.

Zhaoru Gu, Quanyou Wu, Bingqing Shang

|Jul 04, 2023
Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies.

Zhenzhen Zhou, Yuan Pang, Jingyuan Ji

Pageof 2

Frequent Collaborators

1 joint publications

Hongyan Huang

1 joint publications

Xiaoning Wang

1 joint publications

Qiang Sun

1 joint publications

Guoliang Li